Prot #CM-101-PSC-101: A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Evaluating the Safety and Efficacy of CM-101 in Subjects with Primary Sclerosing Cholangitis - The Spring Study

Project: Research project

Project Details

StatusActive
Effective start/end date7/19/227/19/25

Funding

  • Covance Inc. (Prot #CM-101-PSC-101)
  • Chemomab Therapeutics Ltd. (Prot #CM-101-PSC-101)